Of these, 14 significant immune traits were observed in prostate cancer, 5 in colorectal cancer, 4 in breast cancer and lung squamous cell carcinoma, 2 (interleukin [IL]-13 score 21050467 [member of TGF-β response module] and gamma delta T cells (%)) in lung adenocarcinoma, and 1(Troester WoundSig 19887484 [member of TGF-β response module] and eosinophils [member of T-cell/cytotoxic module]) in ovarian and pancreatic cancers. This evidence concerns the gene IL13 and breast carcinoma.